Are you Dr. Pradhan?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 28 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
Unc Chapel Hill Division Of Hematology Oncology
Cb# 7305, 3009 Old Clinic Bldg.
Chapel Hill, NC 27599Phone+1 919-966-1996
Summary
- Dr. Shan Pradhan, MD is an oncologist in Chapel Hill, North Carolina. She is currently licensed to practice medicine in North Carolina.
Education & Training
- University of North Carolina HospitalsFellowship, Hematology and Medical Oncology, 2007 - 2009
- University of Alabama Medical CenterFellowship, Hematology and Medical Oncology, 2006 - 2007
- Creighton University School of Medicine (Phoenix)Residency, Internal Medicine, 2004 - 2006
- UCLA David Geffen School of Medicine/UCLA Medical Center/UCLA Stein and Doheny Eye InstitutesResidency, Ophthalmology, 2003 - 2004
- Creighton University School of Medicine (Phoenix)Internship, Internal Medicine, 2002 - 2003
- Keck School of Medicine of the University of Southern CaliforniaClass of 2002
Certifications & Licensure
- NC State Medical License 2007 - 2025
Publications & Presentations
PubMed
- 3 citationsPostmarketing Colitis Cases Associated With Alpelisib Use Reported to the US Food and Drug Administration.Kathleen M Sullivan, Graça M Dores, Afrouz Nayernama, Tatiana M Prowell, Shan M Pradhan
JAMA Oncology. 2022-10-01 - 50 citationsOptimizing the safety of antibody-drug conjugates for patients with solid tumours.Paolo Tarantino, Biagio Ricciuti, Shan M Pradhan, Sara M Tolaney
Nature Reviews. Clinical Oncology. 2023-08-01 - 22 citationsFDA Approval Summary: Ivosidenib for the Treatment of Patients with Advanced Unresectable or Metastatic, Chemotherapy Refractory Cholangiocarcinoma with an IDH1 Mutation.Sandra J Casak, Shan Pradhan, Lola A Fashoyin-Aje, Yi Ren, Yuan-Li Shen
Clinical Cancer Research. 2022-07-01